This release came out yesterday, there is a typo from prnews it should read This sublingual method of administration promotes excellent
absorption.
La Jolla Diagnostics, Inc. Receives First Bulk Order on New Product
PR Newswire - June 11, 1998 17:10
LAJD %HEA %MTC %PDT V%PRN P%PRN
LA JOLLA, Calif., June 11 /PRNewswire/ -- La Jolla Diagnostics, Inc. (OTC Bulletin Board: LAJD), announced today that it has received the first bulk order on its new oral spray.
The product, a saline solution containing the herb feverfew, is designed to be sprayed under the tongue. This sublingual method of
administration promotes excellent abortion.
Feverfew(TM) is the common name for Tanacetum Parthenium, a flowering plant related to the chrysanthemum, whose leaves have been
used for centuries in herbal remedies for the treatment of various conditions including migraine headaches.
The water used in the solution has been processed by a unique patented technology* to form Cluster Water(TM), which remains
chemically identical with unprocessed water, however when exposed to active biological molecules, the clusters form new polywater
omplexes which take on the structural and electronic "signature" of the biomolecules, a process which may enhance the effectiveness of
he solution.
The order was from G & S Imports, Inc. one of the Company's distributors, who is marketing the oral spray under the name Migrin(TM)
(It is sold under the name MirgraSpray by the Company itself) in conjunction with a recently published book by Douglas Hunt, M.D. titled
Migraine Killers, which features the product.
La Jolla Diagnostics is a company engaged in the development and marketing of diagnostic tests and consumer health care products, and
the licensing of drug delivery systems.
La Jolla Diagnostics, Inc. 7777 Fay Ave, Suite 160, La Jolla, CA 92037 Phone: 800/572-7177 Fax: 619/454-7851, lajd.com
*U.S. Patent 5711950
SOURCE La Jolla Diagnostics, Inc.
/CONTACT: Clent Alexander of La Jolla Diagnostics, Inc., 800-572-7177/
/Web site: lajd.com
(LAJD)
Headlines Next Story
|
